CompanyPrivateCambridge, MA

NextPoint Therapeutics, Inc

SEC EDGAR ClinicalTrials.gov

DJul 30Latest SEC filing

Form DJul 30$34M sold

July 2026

NextPoint Therapeutics discloses $48.7 million private securities offering

Jul 30FinancingNextPoint Therapeutics, Inc